Skip to main content
PatentCliff

Patent Portfolio

The complete collection of patents and pending patent applications owned by a person, company, or organization.

What It Means

A patent portfolio is the aggregate of all patents and patent applications held by a single entity. For large technology and pharmaceutical companies, portfolios can contain thousands or even tens of thousands of active patents spanning multiple technology domains and jurisdictions. The portfolio is a strategic asset that serves multiple functions: it protects the company's own products from copying, creates licensing revenue streams, provides defensive leverage against infringement suits, and signals innovation leadership to investors and partners. Portfolio analysis evaluates the overall quality and strategic value of a patent collection, looking beyond raw patent counts to factors like claims breadth, technology diversity, remaining patent term, and geographic coverage. A company with 500 carefully targeted patents in a single high-value technology area may have a stronger competitive position than a company with 5,000 scattered, low-quality patents. PatentCliff's Patent Strength Score grades portfolios from A (strongest) to F (weakest) based on four factors: portfolio size, claims breadth, time remaining, and technology diversity. Portfolio management is an active discipline: companies regularly review their holdings, letting weak or obsolete patents lapse to save maintenance fees while filing new applications to protect emerging innovations. Acquisitions of patent portfolios, such as Google's $12.5 billion purchase of Motorola Mobility primarily for its patent portfolio, demonstrate the enormous commercial value that well-constructed patent collections can represent.

Frequently Asked Questions

What does Patent Portfolio mean?

The complete collection of patents and pending patent applications owned by a person, company, or organization.

Why is patent portfolio important in patent law?

A patent portfolio is the aggregate of all patents and patent applications held by a single entity. For large technology and pharmaceutical companies, portfolios can contain thousands or even tens of thousands of active patents spanning multiple technology domains and jurisdictions. The portfolio is...

this entity is one of the U.S. pharmaceutical patent expirations concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the the FDA Orange Book and USPTO patent records data behind every per-entity page on the site.

In the the FDA Orange Book and USPTO patent records data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.

Source: USPTO patent search, 2026.